)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Collegium Pharmaceutical
Collegium Pharmaceutical (COLL) investor relations material
Collegium Pharmaceutical Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary5 Nov, 2026
Executive summary
Record Q3 net product revenue of $216.3M, up 3% YoY; ADHD products contributed more than 36% of revenue, while the pain portfolio generated $138.0M.
JORNAY PM reached record revenue, prescription and prescriber levels; AZSTARYS generated $26.5M in its first full quarter under new ownership.
Growth in JORNAY PM and AZSTARYS was partly offset by lower NUCYNTA and XTAMPZA ER revenue; adjusted EBITDA fell 9% YoY to $121.6M.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Collegium Pharmaceutical
- Record 2023 results underpin 2024 growth, debt repayment and shareholder returns.COLL
Q4 2023 - ADHD and pain portfolios drive 8% revenue growth, with strong cash flow fueling expansion.COLLH.C. Wainwright 28th Annual Global Investment Conference
- Diversification into ADHD and disciplined growth strategies position the business for sustained expansion.COLLMorgan Stanley 24th Annual Global Healthcare Conference
- Q2 2026 revenue rose 6% on ADHD and AZSTARYS gains, but net loss followed higher expenses.COLLQ2 2026
- Strong growth and portfolio durability expected, with expanded ADHD presence post-AZSTARYS.COLLJefferies Global Healthcare Conference 2026
- Q1 2026 revenue up 9% with AZSTARYS acquisition set to boost ADHD and pain portfolios.COLLQ1 2026
- ADHD franchise growth and AZSTARYS deal drive 2026 outlook, with stable pain portfolio performance.COLL25th Annual Needham Virtual Healthcare Conference
- Q1 2025 revenue up 23% to $177.8M, driven by ADHD and pain portfolio growth.COLLQ1 2025
- Record 2024 revenue and EBITDA, with Jornay PM and pain portfolio fueling double-digit growth.COLLQ4 2024
Next Collegium Pharmaceutical earnings date
Q4 202625 Feb, 2027
Collegium Pharmaceutical
Next Collegium Pharmaceutical earnings date
Q4 202625 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Collegium Pharmaceutical Inc. is a specialty pharmaceutical company that focuses on developing and commercializing medications for the treatment of pain and related conditions. The company emphasizes the use of innovative drug delivery technologies to create products designed to address medical needs while minimizing potential risks associated with treatment. The company is headquartered in Stoughton, Massachusetts, and its shares are listed on the NASDAQ.